Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Anders · SciRah

Researcher profile · Semantic Scholar

C. Anders

Share profile

C. Anders — researcher profile on SciRah

h-index: 61
Works: 303
Citations: 14K

Most-cited papers

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.
R. Murthy, S. Loi, A. Okines, E. Paplomata +28 more
2019New England Journal of Medicine1,094 citations Open access
Semantic Scholar
Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial
N. Lin, V. Borges, C. Anders, R. Murthy +25 more
2020Journal of Clinical Oncology447 citations Open access
Semantic Scholar
ANG1005, a Brain-Penetrating Peptide–Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases
P. Kumthekar, Shou-Ching Tang, A. Brenner, S. Kesari +12 more
2020Clinical Cancer Research201 citations Open access
Semantic Scholar
Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain Metastases
N. Lin, R. Murthy, V. Abramson, C. Anders +23 more
2022JAMA Oncology184 citations Open access
Semantic Scholar
A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–Positive Breast Cancer
S. Tolaney, S. Sahebjam, É. Le Rhun, T. Bachelot +12 more
2020Clinical Cancer Research165 citations Open access
Semantic Scholar
Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Guideline Update
S. Giordano, M. Franzoi, S. Temin, C. Anders +10 more
2022Journal of Clinical Oncology148 citations Open access
Semantic Scholar
Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis
S. Garcia-Recio, T. Hinoue, Gregory L. Wheeler, Benjamin J. Kelly +53 more
2022Nature Cancer142 citations Open access
Semantic Scholar
Current multidisciplinary management of brain metastases
M. Moravan, P. Fecci, C. Anders, J. Clarke +8 more
2020Cancer114 citations Open access
Semantic Scholar
HER2‐positive breast cancer brain metastasis: A new and exciting landscape
A. Zimmer, Amanda E. D. Van Swearingen, C. Anders
2020Cancer Reports102 citations Open access
Semantic Scholar
Management of Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases: ASCO Guideline Update
N. Ramakrishna, C. Anders, N. Lin, A. Morikawa +10 more
2022Journal of Clinical Oncology92 citations Open access
Semantic Scholar
Brain Metastasis Cell Lines Panel: a public resource of organotropic cell lines
M. Valiente, Amanda E. D. Van Swearingen, C. Anders, A. Bairoch +22 more
2020Cancer Research89 citations Open access
Semantic Scholar
Preclinical and clinical efficacy of trastuzumab deruxtecan in breast cancer brain metastases
S. Kabraji, Jing Ni, S. Sammons, Tian-Yu Li +15 more
2022Clinical Cancer Research68 citations Open access
Semantic Scholar
Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and/or BRCA mutation-associated breast cancer (S1416): a randomised, phase 2 trial
E. Rodler, Priyanka Sharma, W. Barlow, J. Gralow +17 more
2023The Lancet Oncology67 citations Open access
Semantic Scholar
Durable responses in patients with HER2+ breast cancer and leptomeningeal metastases treated with trastuzumab deruxtecan
L. Alder, D. Trapani, C. Bradbury, A. V. Van Swearingen +7 more
2023npj Breast Cancer48 citations Open access
Semantic Scholar
Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase
J. Sachdev, P. Munster, D. Northfelt, Hyo S. Han +8 more
2020Breast Cancer Research and Treatment42 citations Open access
Semantic Scholar
Results of a phase II randomized trial of cisplatin +/- veliparib in metastatic triple-negative breast cancer (TNBC) and/or germline BRCA-associated breast cancer (SWOG S1416).
Priyanka Sharma, E. Rodler, W. Barlow, J. Gralow +16 more
202041 citations
Semantic Scholar
Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast Cancer
James Isaacs, C. Anders, H. McArthur, J. Force
2021Current Treatment Options in Oncology38 citations
Semantic Scholar
Effects of Breast Cancer Adjuvant Chemotherapy Regimens on Expression of the Aging Biomarker, p16INK4a
S. S. Shachar, A. Deal, K. Reeder-Hayes, K. Nyrop +10 more
2020JNCI Cancer Spectrum30 citations Open access
Semantic Scholar
National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities
Michelle M. Kim, M. Mehta, D. Smart, P. Steeg +40 more
2023The Lancet Oncology26 citations Open access
Semantic Scholar
Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical Trial.
D. Tripathy, S. Tolaney, A. Seidman, C. Anders +11 more
2022JAMA Oncology24 citations Open access
Semantic Scholar
Salting the soil: Targeting the microenvironment of brain metastases
E. Srinivasan, A. Tan, C. Anders, A. Pendergast +4 more
2021Molecular Cancer Therapeutics23 citations Open access
Semantic Scholar
Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference
R. Rahman, M. Polley, L. Alder, P. Brastianos +10 more
2023The Lancet Oncology19 citations Open access
Semantic Scholar
What's the Price? Toxicities of Targeted Therapies in Breast Cancer Care.
C. Anders, N. Leboeuf, L. Bashoura, S. Faiz +2 more
2020American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting19 citations
Semantic Scholar
Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases
Sarah Jenkins, Wei Zhang, S. Steinberg, Darryl Nousome +23 more
2023Clinical Cancer Research18 citations Open access
Semantic Scholar
Dose-finding and -expansion studies of trastuzumab deruxtecan in combination with other anti-cancer agents in patients (pts) with advanced/metastatic HER2+ (DESTINY-Breast07 [DB-07]) and HER2-low (DESTINY-Breast08 [DB-08]) breast cancer (BC).
F. André, E. Hamilton, S. Loi, S. Im +12 more
2022Journal of Clinical Oncology18 citations
Semantic Scholar
Trastuzumab deruxtecan (T-DXd) combinations in patients with HER2-positive advanced or metastatic breast cancer: A phase 1b/2, open-label, multicenter, dose-finding and dose-expansion study (DESTINY-Breast07).
F. André, E. Hamilton, S. Loi, P. Schmid +6 more
202117 citations
Semantic Scholar
Outcomes in Patients With 4 to 10 Brain Metastases Treated With Dose-Adapted Single-Isocenter Multitarget Stereotactic Radiosurgery: A Prospective Study
Grace J. Kim, E. Buckley, J. Herndon, K. Allen +15 more
2021Advances in Radiation Oncology17 citations Open access
Semantic Scholar
Efficacy of a Dual-epitope DC Vaccine as Part of Combined Immunotherapy for HER2-expressing Breast Tumors
B. Vincent, D. File, K. McKinnon, D. Moore +14 more
2023Journal of Immunology16 citations Open access
Semantic Scholar
Development of next-generation tumor-homing induced neural stem cells to enhance treatment of metastatic cancers
Wulin Jiang, Yu-Chen Yang, Alison R. Mercer-Smith, A. Valdivia +7 more
2021Science Advances15 citations Open access
Semantic Scholar
Physical Activity, Weight, and Outcomes in Patients Receiving Chemotherapy for Metastatic Breast Cancer (C40502/Alliance)
J. Ligibel, L. Huebner, H. Rugo, H. Burstein +9 more
2021JNCI Cancer Spectrum15 citations Open access
Semantic Scholar
Triple Negative Breast Cancer and Brain Metastases.
R. Bansal, Amanda E. D. Van Swearingen, C. Anders
2023Clinical Breast Cancer13 citations
Semantic Scholar
Advances in the management of breast cancer brain metastases
S. Sammons, Amanda E. D. Van Swearingen, C. Chung, C. Anders
2021Neuro-Oncology Advances13 citations Open access
Semantic Scholar
Tucatinib versus placebo added to trastuzumab and capecitabine for patients with previously treated HER2+ metastatic breast cancer with brain metastases (HER2CLIMB).
N. Lin, R. Murthy, C. Anders, V. Borges +16 more
202012 citations
Semantic Scholar
The Enduring Effects of COVID for Cancer Care: Learning from real life clinical practice
A. Broom, Leah Williams Veazey, Katherine Kenny, Imogen Harper +13 more
2023Clinical Cancer Research11 citations Open access
Semantic Scholar
Inpatient palliative care utilization for patients with brain metastases.
Meghan J. Price, E. Howell, Tara Dalton, L. Ramirez +7 more
2021Neuro-Oncology Practice11 citations Open access
Semantic Scholar
Outcomes In Patients With 4-10 Brain Metastases Treated With Dose-Adapted Single-Isocenter Multitarget Stereotactic Radiosurgery: A Prospective Study
Grace J. Kim, E. Buckley, J. Herndon, K. Allen +15 more
202011 citations
Semantic Scholar
A Need for More Molecular Profiling in Brain Metastases
Erica Y. Shen, Amanda E. D. Van Swearingen, Meghan J. Price, K. Bulsara +10 more
2022Frontiers in Oncology10 citations Open access
Semantic Scholar
Systemic Therapy Type and Timing Effects on Radiation Necrosis Risk in HER2+ Breast Cancer Brain Metastases Patients Treated With Stereotactic Radiosurgery
Christine Park, E. Buckley, Amanda E. D. Van Swearingen, W. Giles +4 more
2022Frontiers in Oncology10 citations Open access
Semantic Scholar
Comprehensive Analysis of the Immunogenomics of Triple-Negative Breast Cancer Brain Metastases From LCCC1419
Eric D. Routh, A. V. Van Swearingen, M. Sambade, Steven P Vensko +11 more
2022Frontiers in Oncology10 citations Open access
Semantic Scholar
Abstract CT255: ELU-FRα-1: a study to evaluate ELU001 in patients with solid tumors that overexpress folate receptor alpha (FRα)
Wen W. Ma, A. Tolcher, C. Perez, D. Orr +7 more
2023Cancer Research9 citations
Semantic Scholar
Alliance A071701: Genomically guided treatment trial in brain metastases.
P. Brastianos, E. Twohy, C. Anders, A. Iafrate +12 more
20209 citations
Semantic Scholar
Genomic evaluation of tumor mutational burden-high (TMB-H) versus TMB-low (TMB-L) metastatic breast cancer to reveal unique mutational features.
Sarah Sammons, A. Elliott, J. Force, N. DeVito +9 more
20218 citations
Semantic Scholar
Phase 1 trial of a novel C’Dot drug conjugate (CDC), ELU001, in patients with solid tumors known to overexpress folate receptor alpha (FRα).
Wen W. Ma, A. Tolcher, C. Perez, D. Orr +7 more
2023Journal of Clinical Oncology7 citations
Semantic Scholar
Available Systemic Treatments and Emerging Therapies for Breast Cancer Brain Metastases
Ryan K. Rader, C. Anders, N. Lin, S. Sammons
2023Current Treatment Options in Oncology7 citations
Semantic Scholar
Abstract PD4-05: Preclinical and clinical efficacy of trastuzumab deruxtecan in breast cancer brain metastases (BCBM)
S. Kabraji, Jing Ni, S. Sammons, A. V. Van Swearingen +13 more
2022Cancer Research6 citations
Semantic Scholar
Management of Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Guideline Update Q and A.
N. Ramakrishna, C. Anders, S. Temin
2022JCO Oncology Practice5 citations
Semantic Scholar
Trial in progress: Phase 1a/b study of PF-07284890 (brain-penetrant BRAF inhibitor) with/without binimetinib in patients with BRAF V600-mutant solid tumors.
V. Subbiah, M. Gutierrez, C. Anders, G. Ansstas +15 more
2021Journal of Clinical Oncology5 citations
Semantic Scholar
Receptor Discordance in Breast Cancer Brain Metastases: When Knowledge is Power.
S. Sammons, Amanda E. D. Van Swearingen, C. Anders
2020Neuro-Oncology5 citations Open access
Semantic Scholar
Real-world patient characteristics and treatment patterns associated with tucatinib therapy in patients with HER2+ metastatic breast cancer.
C. Anders, E. Neuberger, N. Schwartz, K. Bartley +6 more
2023Journal of Clinical Oncology4 citations
Semantic Scholar
Brain metastasis as the first and only metastatic relapse site portends worse survival in patients with advanced HER2 + breast cancer
Laura Noteware, G. Broadwater, N. Dalal, L. Alder +6 more
2022Breast Cancer Research and Treatment4 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Lin×12
Invite
N. Lin — researcher profile on SciRah
L. Carey×8
Invite
L. Carey — researcher profile on SciRah
Amanda E. D. Van Swearingen×8
Invite
Amanda E. D. Van Swearingen — researcher profile on SciRah
R. Murthy×6
Invite
R. Murthy — researcher profile on SciRah

×6

Invite

S. Loi — researcher profile on SciRah

Invite

E. Hamilton — researcher profile on SciRah

Invite

M. Khasraw — researcher profile on SciRah

Invite

T. Bachelot — researcher profile on SciRah

Invite

I. Krop — researcher profile on SciRah

Invite

E. Winer — researcher profile on SciRah

Invite

S. Floyd — researcher profile on SciRah

Invite

S. Sammons — researcher profile on SciRah